311 related articles for article (PubMed ID: 9443455)
1. Unexpected sarcolemmal complement membrane attack complex deposits on nonnecrotic muscle fibers in muscular dystrophies.
Spuler S; Engel AG
Neurology; 1998 Jan; 50(1):41-6. PubMed ID: 9443455
[TBL] [Abstract][Full Text] [Related]
2. S-protein is expressed in necrotic fibers in Duchenne muscular dystrophy and polymyositis.
Louboutin JP; Navenot JM; Rouger K; Blanchard D
Muscle Nerve; 2003 May; 27(5):575-81. PubMed ID: 12707977
[TBL] [Abstract][Full Text] [Related]
3. X-linked vacuolated myopathy: membrane attack complex deposition on the surface membrane of injured muscle fibers is not accompanied by S-protein.
Louboutin JP; Navenot JM; Villanova M; Rouger K; Merlini L; Fardeau M
Muscle Nerve; 1998 Jul; 21(7):932-5. PubMed ID: 9626253
[TBL] [Abstract][Full Text] [Related]
4. The earliest pathologic alterations in dysferlinopathy.
Selcen D; Stilling G; Engel AG
Neurology; 2001 Jun; 56(11):1472-81. PubMed ID: 11402103
[TBL] [Abstract][Full Text] [Related]
5. Immunohistological analysis of CD59 and membrane attack complex of complement in muscle in juvenile dermatomyositis.
Gonçalves FG; Chimelli L; Sallum AM; Marie SK; Kiss MH; Ferriani VP
J Rheumatol; 2002 Jun; 29(6):1301-7. PubMed ID: 12064850
[TBL] [Abstract][Full Text] [Related]
6. Complement activation in muscle fiber necrosis: demonstration of the membrane attack complex of complement in necrotic fibers.
Engel AG; Biesecker G
Ann Neurol; 1982 Sep; 12(3):289-96. PubMed ID: 6753731
[TBL] [Abstract][Full Text] [Related]
7. Muscle inflammation and MHC class I up-regulation in muscular dystrophy with lack of dysferlin: an immunopathological study.
Confalonieri P; Oliva L; Andreetta F; Lorenzoni R; Dassi P; Mariani E; Morandi L; Mora M; Cornelio F; Mantegazza R
J Neuroimmunol; 2003 Sep; 142(1-2):130-6. PubMed ID: 14512171
[TBL] [Abstract][Full Text] [Related]
8. Differential immunohistological features of inflammatory myopathies and dysferlinopathy.
Choi JH; Park YE; Kim SI; Kim JI; Lee CH; Park KH; Kim DS
J Korean Med Sci; 2009 Dec; 24(6):1015-23. PubMed ID: 19949654
[TBL] [Abstract][Full Text] [Related]
9. Immunocytochemical localisation of complement components C8 and C9 in human diseased muscle. The role of complement in muscle fibre damage.
Sewry CA; Dubowitz V; Abraha A; Luzio JP; Campbell AK
J Neurol Sci; 1987 Nov; 81(2-3):141-53. PubMed ID: 3694223
[TBL] [Abstract][Full Text] [Related]
10. CD4+ cells, macrophages, MHC-I and C5b-9 involve the pathogenesis of dysferlinopathy.
Yin X; Wang Q; Chen T; Niu J; Ban R; Liu J; Mao Y; Pu C
Int J Clin Exp Pathol; 2015; 8(3):3069-75. PubMed ID: 26045819
[TBL] [Abstract][Full Text] [Related]
11. Muscle pathology and clinical features of the sarcolemmopathies.
Fadic R; Waclawik AJ; Lewandoski PJ; Lotz BP
Pediatr Neurol; 1997 Jan; 16(1):79-82. PubMed ID: 9044410
[TBL] [Abstract][Full Text] [Related]
12. Membrane attack complex deposits in cutaneous lesions of dermatomyositis.
Mascaró JM; Hausmann G; Herrero C; Grau JM; Cid MC; Palou J; Mascaró JM
Arch Dermatol; 1995 Dec; 131(12):1386-92. PubMed ID: 7492126
[TBL] [Abstract][Full Text] [Related]
13. Major histocompatibility complex class I expression can be used as a diagnostic tool to differentiate idiopathic inflammatory myopathies from dystrophies.
Sundaram C; Uppin MS; Meena AK
Neurol India; 2008; 56(3):363-7. PubMed ID: 18974565
[TBL] [Abstract][Full Text] [Related]
14. Basement membrane abnormality in merosin-negative congenital muscular dystrophy.
Osari S; Kobayashi O; Yamashita Y; Matsuishi T; Goto M; Tanabe Y; Migita T; Nonaka I
Acta Neuropathol; 1996; 91(4):332-6. PubMed ID: 8928608
[TBL] [Abstract][Full Text] [Related]
15. Massive muscle cell degeneration in the early stage of merosin-deficient congenital muscular dystrophy.
Hayashi YK; Tezak Z; Momoi T; Nonaka I; Garcia CA; Hoffman EP; Arahata K
Neuromuscul Disord; 2001 May; 11(4):350-9. PubMed ID: 11369186
[TBL] [Abstract][Full Text] [Related]
16. Myopathy associated with anti-signal recognition peptide antibodies: clinical heterogeneity contrasts with stereotyped histopathology.
Dimitri D; Andre C; Roucoules J; Hosseini H; Humbel RL; Authier FJ
Muscle Nerve; 2007 Mar; 35(3):389-95. PubMed ID: 17143889
[TBL] [Abstract][Full Text] [Related]
17. Monoclonal antibody analysis of mononuclear cells in myopathies. I: Quantitation of subsets according to diagnosis and sites of accumulation and demonstration and counts of muscle fibers invaded by T cells.
Arahata K; Engel AG
Ann Neurol; 1984 Aug; 16(2):193-208. PubMed ID: 6383191
[TBL] [Abstract][Full Text] [Related]
18. Expression of CD59, a regulator of the membrane attack complex of complement, on human skeletal muscle fibers.
Navenot JM; Villanova M; Lucas-Héron B; Malandrini A; Blanchard D; Louboutin JP
Muscle Nerve; 1997 Jan; 20(1):92-6. PubMed ID: 8995588
[TBL] [Abstract][Full Text] [Related]
19. Statistically significant differences in the number of CD24 positive muscle fibers and satellite cells between sarcoglycanopathy and age-matched Becker muscular dystrophy patients.
Higuchi I; Kawai H; Kawajiri M; Fukunaga H; Horikiri T; Niiyama T; Nakagawa M; Arimura K; Osame M
Intern Med; 1999 May; 38(5):412-5. PubMed ID: 10397078
[TBL] [Abstract][Full Text] [Related]
20. Necrotizing myopathy with microvascular deposition of the complement membrane attack complex.
De Bleecker J; Vervaet V; Van den Bergh P
Clin Neuropathol; 2004; 23(2):76-9. PubMed ID: 15074581
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
